142 related articles for article (PubMed ID: 15085931)
1. Intracellular proteins and mechanisms involved in the control of gp130/JAK/STAT cytokine signaling.
Carbia-Nagashima A; Arzt E
IUBMB Life; 2004 Feb; 56(2):83-8. PubMed ID: 15085931
[TBL] [Abstract][Full Text] [Related]
2. The Jak-STAT pathway stimulated by interleukin 6.
Horvath CM
Sci STKE; 2004 Nov; 2004(260):tr9. PubMed ID: 15561981
[TBL] [Abstract][Full Text] [Related]
3. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
Hirano T; Ishihara K; Hibi M
Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
Himpe E; Kooijman R
Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
[TBL] [Abstract][Full Text] [Related]
5. Jak-STAT signaling pathways in cells of the immune system.
Ivashkiv LB
Rev Immunogenet; 2000; 2(2):220-30. PubMed ID: 11258419
[TBL] [Abstract][Full Text] [Related]
6. Polarity and lipid raft association of the components of the ciliary neurotrophic factor receptor complex in Madin-Darby canine kidney cells.
Buk DM; Waibel M; Braig C; Martens AS; Heinrich PC; Graeve L
J Cell Sci; 2004 Apr; 117(Pt 10):2063-75. PubMed ID: 15054106
[TBL] [Abstract][Full Text] [Related]
7. A novel type-1 cytokine receptor from fish involved in the Janus kinase/signal transducers and activators of transcription (Jak/STAT) signal pathway.
Santos MD; Yasuike M; Kondo H; Hirono I; Aoki T
Mol Immunol; 2007 Jul; 44(13):3355-63. PubMed ID: 17383728
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
Selander KS; Li L; Watson L; Merrell M; Dahmen H; Heinrich PC; Müller-Newen G; Harris KW
Cancer Res; 2004 Oct; 64(19):6924-33. PubMed ID: 15466183
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription STAT3 plays a major role in gp130-mediated acute phase protein gene activation.
May P; Schniertshauer U; Gerhartz C; Horn F; Heinrich PC
Acta Biochim Pol; 2003; 50(3):595-601. PubMed ID: 14515142
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of the JAK/STAT pathway.
Starr R; Hilton DJ
Bioessays; 1999 Jan; 21(1):47-52. PubMed ID: 10070253
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS.
Campbell IL
Brain Res Brain Res Rev; 2005 Apr; 48(2):166-77. PubMed ID: 15850655
[TBL] [Abstract][Full Text] [Related]
12. Cytokines and JAK-STAT signaling.
Schindler C
Exp Cell Res; 1999 Nov; 253(1):7-14. PubMed ID: 10579906
[TBL] [Abstract][Full Text] [Related]
13. Cytokine signalling in embryonic stem cells.
Kristensen DM; Kalisz M; Nielsen JH
APMIS; 2005; 113(11-12):756-72. PubMed ID: 16480448
[TBL] [Abstract][Full Text] [Related]
14. STATs as critical mediators of signal transduction and transcription: lessons learned from STAT5.
Paukku K; Silvennoinen O
Cytokine Growth Factor Rev; 2004 Dec; 15(6):435-55. PubMed ID: 15561601
[TBL] [Abstract][Full Text] [Related]
15. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.
Tao W; Wen F; Zhang H; Liu G
Brain Dev; 2009 Mar; 31(3):200-7. PubMed ID: 18715729
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M: a pleiotropic cytokine in the central nervous system.
Chen SH; Benveniste EN
Cytokine Growth Factor Rev; 2004 Oct; 15(5):379-91. PubMed ID: 15450253
[TBL] [Abstract][Full Text] [Related]
17. Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart.
Terrell AM; Crisostomo PR; Wairiuko GM; Wang M; Morrell ED; Meldrum DR
Shock; 2006 Sep; 26(3):226-34. PubMed ID: 16912647
[TBL] [Abstract][Full Text] [Related]
18. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of type I interferon signaling in normal and malignant cells.
Li Y; Srivastava KK; Platanias LC
Arch Immunol Ther Exp (Warsz); 2004; 52(3):156-63. PubMed ID: 15247882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
